XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.4120
+0.0170 (4.30%)
Mar 23, 2026, 9:30 AM EDT - Market open
XORTX Therapeutics Market Cap
XORTX Therapeutics has a market cap or net worth of $3.25 million as of March 23, 2026. Its market cap has decreased by -27.30% in one year.
Market Cap
3.25M
Enterprise Value
2.43M
1-Year Change
-27.30%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since January 11, 2018, XORTX Therapeutics's market cap has decreased from $25.10M to $3.25M, a decrease of -87.04%. That is a compound annual growth rate of -22.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 3.25M | -16.93% |
| Dec 30, 2025 | 3.92M | -4.18% |
| Dec 30, 2024 | 4.09M | -6.85% |
| Dec 29, 2023 | 4.39M | -63.14% |
| Dec 30, 2022 | 11.91M | -53.60% |
| Dec 31, 2021 | 25.66M | 177.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 4.10M |
| Silexion Therapeutics | 4.06M |
| Indaptus Therapeutics | 3.81M |
| Purple Biotech | 3.70M |
| Aspire Biopharma Holdings | 3.61M |
| GRI Bio | 3.41M |
| Galmed Pharmaceuticals | 3.29M |
| Oragenics | 3.23M |